Back to Ticker
Orchid Pharma Limited
NSE: ORCHPHARMA₹893.5
-1.95%EOD · 19 OctMarket Cap
₹4,532 Cr
52W Range
₹1144 / ₹480
Volume
127K
27.1% delivery
1Y Return
+19.8%
P/E Ratio
566.0
P/B Ratio
3.6
Debt / Equity
28.16
Quality Score
Durability · Valuation · Momentum — objective math, not adviceC
44/100
Composite score: 40% quality, 30% valuation, 30% momentum
QualityWeak · 35
ValuationPoor · 20
MomentumStrong · 80
High debt load (D/E 28.2)
In confirmed uptrend (Stage 2)
Very expensive valuation (P/E 566x)
Technical Indicators
Full analysis · objective math, not adviceReturns
1D
-1.9%
1W
-8.8%
1M
-6.7%
3M
-14.6%
6M
+56.9%
1Y
+19.8%
Weinstein Stage
Stage 2 — Advancing (uptrend) RSI (14)
24 Oversold
Trend Template
6/7strong
RS vs Nifty (3M)
-8.2pp
Moving Averages (price vs MA)
20-DMA
₹1003
below
50-DMA
₹997
below
150-DMA
₹850
above
200-DMA
₹809
above
From 52W High
-21.9%
From 52W Low
+86.1%
Support (20D)
₹875
Resistance (20D)
₹1144
Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.
News & FilingsGoogle News + BSE
Orchid Pharma ORCHPHARMA Q2 FY27 Reg 74(5) Certificate Filed
Kalkine India· 9 OctSome May Be Optimistic About Orchid Pharma's (NSE:ORCHPHARMA) Earnings
Simply Wall Street· 1 JunOrchid Pharma Share Price Target 2026: Bull Case Rs 1,070, Bear C
Univest· 2 JulOrchid Pharma (NSE: ORCHPHARMA) Property Acquisition and Merger Share Listing Update
Kalkine India· 23 SeptORCHPHARMA Stock Price and Chart — NSE:ORCHPHARMA
TradingView· 2 NovOrchid Pharma | Stock Share Price Live
MarketSmith India· 15 Oct
News via Google News · Not verified by IPOpulse · Not investment advice
Community discussion(0)
Sign in to join the discussion.
Sign inNo comments yet — be the first to share your view.